Zacks Investment Research on MSN

Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals

In the first nine months of 2025, Tempus AI Inc. TEM achieved several key regulatory milestones that strengthened its position in AI-driven diagnostics. In September 2025, the company received FDA 510 ...
Seeking Alpha

Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510(k) clearance from ...
Hosted on MSN

Why Is Tempus AI Stock (TEM) Rising in Premarket Trading Today?

U.S.-based Tempus AI (TEM) stock is up in early trading on Monday. Yesterday, the company received FDA clearance for its RNA-based Tempus xR IVD device. Following the news, TEM stock hit an all-time ...
Morningstar

Countable Labs Launches Revolutionary Ten-Color PCR Platform, Bridging the Gap Between PCR and Next-Generation Sequencing Technologies

Giovanna Prout joins Countable Labs as CEO to accelerate commercialization of Countable Labs’ products Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a ...